Although, PNETs and angiofibromas are equally common in MEN1 patients, BON1 cells and MEFs show variable response to rapamycin, and BON1 cells with downregulated menin display a more pronounced rapamycin resistance phenotype. This evidence concerns the gene MEN1 and Angiofibromas.